8-K filed August 9, 2023, 7:59 PM ET ticker TLSI CIK 0001826667

M&A confidence high sentiment neutral materiality 0.75

MedTech Acquisition shareholders approve TriSalus merger; $9.4M redeemed

TriSalus Life Sciences, Inc.

All 14 proposals approved by >99% of votes cast at August 8 special meeting.
Holders of 890,499 Class A shares elected redemption for ~$9.42M ($10.58/share) from trust.
Business combination with TriSalus expected to close subject to conditions.
Combined company securities to trade on Nasdaq under symbols TLSI (common) and TLSIW (warrants).
Adjournment proposal not presented due to sufficient votes for all proposals.

item 5.07 item 8.01

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TriSalus Life Sciences, Inc. shareholders approved Governance Proposal 3A at the 2023-08-08 meeting.

Outcome: passed
Meeting: 2023-08-08

Exact text from the filing

3A. Governance Proposal 3A : For Against Abstain 7,134,005 20,016 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

TriSalus Life Sciences, Inc. shareholders approved The Charter Approval Proposal at the 2023-08-08 meeting.

Proposal: charter amendment
Outcome: passed
Meeting: 2023-08-08

Exact text from the filing

2. The Charter Approval Proposal : i. Class A Common Stock For Against Abstain 7,135,004 19,016 0 ii. Class B Common Stock For Against Abstain 1 0 0 iii. Total Common Stock For Against Abstain 7,135,005 19,016 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TriSalus Life Sciences, Inc. shareholders approved The Nasdaq Proposal at the 2023-08-08 meeting.

Outcome: passed
Meeting: 2023-08-08

Exact text from the filing

6. The Nasdaq Proposal : For Against Abstain 7,135,005 19,016 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TriSalus Life Sciences, Inc. shareholders approved Governance Proposal 3D at the 2023-08-08 meeting.

Outcome: passed
Meeting: 2023-08-08

Exact text from the filing

3D. Governance Proposal 3D : For Against Abstain 7,135,005 19,016 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

TriSalus Life Sciences, Inc. shareholders approved Director Nomination Proposal B at the 2023-08-08 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-08-08

Exact text from the filing

7B. Director Nomination Proposal B : i. David J. Matlin For Withheld 7,135,005 19,016

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TriSalus Life Sciences, Inc. shareholders approved Governance Proposal 3C at the 2023-08-08 meeting.

Outcome: passed
Meeting: 2023-08-08

Exact text from the filing

3C. Governance Proposal 3C : For Against Abstain 7,135,005 19,016 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

TriSalus Life Sciences, Inc. shareholders approved The Business Combination Proposal at the 2023-08-08 meeting.

Proposal: merger approval
Outcome: passed
Meeting: 2023-08-08

Exact text from the filing

1. The Business Combination Proposal : For Against Abstain 7,135,003 19,016 2

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TriSalus Life Sciences, Inc. shareholders approved Governance Proposal 3B at the 2023-08-08 meeting.

Outcome: passed
Meeting: 2023-08-08

Exact text from the filing

3B. Governance Proposal 3B : For Against Abstain 7,135,005 19,016 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

TriSalus Life Sciences, Inc. shareholders approved The Stock Plan Proposal at the 2023-08-08 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-08-08

Exact text from the filing

4. The Stock Plan Proposal : For Against Abstain 7,135,000 19,021 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TriSalus Life Sciences, Inc. shareholders approved Governance Proposal 3E at the 2023-08-08 meeting.

Outcome: passed
Meeting: 2023-08-08

Exact text from the filing

3E. Governance Proposal 3E : For Against Abstain 7,135,005 19,016 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TriSalus Life Sciences, Inc. shareholders approved The ESPP Proposal at the 2023-08-08 meeting.

Outcome: passed
Meeting: 2023-08-08

Exact text from the filing

5. The ESPP Proposal : For Against Abstain 7,135,000 19,021 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

TriSalus Life Sciences, Inc. shareholders approved Director Nomination Proposal A at the 2023-08-08 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-08-08

Exact text from the filing

7A. Director Nomination Proposal A : i. Anil Singhal For Withheld 7,135,005 19,016

View on SEC.gov

560 shareholder votes filed in the last 30 days. Browse all shareholder votes →

TriSalus Life Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-089074

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.